Xintela AB Sustainability Reports
Xintela AB is a clinical-stage biomedical company that develops targeted cancer therapies and stem cell-based regenerative solutions for degenerative joint diseases. The company operates its own GMP-certified manufacturing facility to produce advanced therapy medical products.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300SMDH1EOLCBQU68
FIGI: BBG006XVSX08
9 reports from 2017 to 2025
